Enterovirus RNA in blood is linked to the development of type 1 diabetes

Sami Oikarinen1, Mika Martiskainen, Sisko Tauriainen

  • 1Department of Virology, University of Tampere, Finland. sami.oikarinen@uta.fi

Diabetes
|October 15, 2010
PubMed

Insights

Detecting enterovirus RNA in blood can predict type 1 diabetes development. This virus may initiate the beta-cell damage process, with higher risk observed in boys.

Area of Science:

  • Virology
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes is an autoimmune disease with increasing incidence.
  • The role of viral infections, particularly enteroviruses, in type 1 diabetes pathogenesis is debated.
  • Understanding early triggers is crucial for prevention strategies.

Purpose of the Study:

  • To determine if enterovirus RNA detection in blood predicts clinical type 1 diabetes.
  • To investigate the role of enteroviruses in initiating and progressing type 1 diabetes.
  • To explore potential sex-specific differences in enterovirus-associated risk.

Main Methods:

  • A nested case-control study design was employed.
  • Case children (N=38) developed clinical type 1 diabetes; controls (N=140) were matched for key factors.
  • Serum samples were analyzed for enterovirus RNA using RT-PCR.

Main Results:

  • Enterovirus RNA was detected more frequently in type 1 diabetes cases (5.1%) than controls (1.9%).
  • Enterovirus RNA positivity in the 6 months before autoantibody detection significantly increased type 1 diabetes risk (OR 7.7).
  • The risk associated with enteroviruses was notably higher in boys than in girls.

Conclusions:

  • Findings support the hypothesis that enteroviruses contribute to type 1 diabetes development.
  • Enteroviruses likely play a role in initiating the autoimmune process targeting pancreatic beta cells.
  • The enterovirus-associated risk for type 1 diabetes appears to be stronger in males.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...